nodes	percent_of_prediction	percent_of_DWPC	metapath
Lithium—GSK3A—penis—metabolic syndrome X	0.108	0.303	CbGeAlD
Lithium—IMPA1—cardiovascular system—metabolic syndrome X	0.0272	0.0762	CbGeAlD
Lithium—IMPA1—kidney—metabolic syndrome X	0.0266	0.0745	CbGeAlD
Lithium—GSK3B—cardiovascular system—metabolic syndrome X	0.02	0.0561	CbGeAlD
Lithium—IMPA2—kidney—metabolic syndrome X	0.02	0.0559	CbGeAlD
Lithium—GSK3B—kidney—metabolic syndrome X	0.0196	0.0549	CbGeAlD
Lithium—IMPA2—adipose tissue—metabolic syndrome X	0.018	0.0504	CbGeAlD
Lithium—GSK3B—adipose tissue—metabolic syndrome X	0.0177	0.0495	CbGeAlD
Lithium—GSK3A—cardiovascular system—metabolic syndrome X	0.0174	0.0488	CbGeAlD
Lithium—IMPA1—liver—metabolic syndrome X	0.0168	0.0471	CbGeAlD
Lithium—GSK3A—adipose tissue—metabolic syndrome X	0.0153	0.043	CbGeAlD
Lithium—GRIA3—liver—metabolic syndrome X	0.0143	0.0401	CbGeAlD
Lithium—IMPA2—liver—metabolic syndrome X	0.0126	0.0354	CbGeAlD
Lithium—GSK3B—liver—metabolic syndrome X	0.0124	0.0347	CbGeAlD
Lithium—GSK3A—liver—metabolic syndrome X	0.0108	0.0302	CbGeAlD
Lithium—Taste metallic—Metformin—metabolic syndrome X	0.00365	0.206	CcSEcCtD
Lithium—Chest discomfort—Metformin—metabolic syndrome X	0.00131	0.0741	CcSEcCtD
Lithium—Lethargy—Metformin—metabolic syndrome X	0.00086	0.0485	CcSEcCtD
Lithium—Dehydration—Metformin—metabolic syndrome X	0.000784	0.0442	CcSEcCtD
Lithium—Drowsiness—Metformin—metabolic syndrome X	0.000649	0.0367	CcSEcCtD
Lithium—Bradycardia—Metformin—metabolic syndrome X	0.000593	0.0335	CcSEcCtD
Lithium—Flatulence—Metformin—metabolic syndrome X	0.0005	0.0282	CcSEcCtD
Lithium—Dysgeusia—Metformin—metabolic syndrome X	0.000497	0.0281	CcSEcCtD
Lithium—GSK3B—Constitutive PI3K/AKT Signaling in Cancer—AKT1—metabolic syndrome X	0.000491	0.000786	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—IRS1—metabolic syndrome X	0.000487	0.000778	CbGpPWpGaD
Lithium—GSK3A—Signaling by SCF-KIT—IL6—metabolic syndrome X	0.000485	0.000776	CbGpPWpGaD
Lithium—IMPA2—Metabolism—INS—metabolic syndrome X	0.000483	0.000772	CbGpPWpGaD
Lithium—Vision blurred—Metformin—metabolic syndrome X	0.000478	0.027	CcSEcCtD
Lithium—GSK3B—Androgen receptor signaling pathway—AKT1—metabolic syndrome X	0.000478	0.000765	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—CD36—metabolic syndrome X	0.000477	0.000763	CbGpPWpGaD
Lithium—Tremor—Metformin—metabolic syndrome X	0.000475	0.0268	CcSEcCtD
Lithium—GSK3A—Metabolism of proteins—IGF2—metabolic syndrome X	0.000474	0.000757	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	0.000472	0.000754	CbGpPWpGaD
Lithium—GSK3B—Corticotropin-releasing hormone—AKT1—metabolic syndrome X	0.000466	0.000745	CbGpPWpGaD
Lithium—GSK3A—Downstream signaling of activated FGFR—IL6—metabolic syndrome X	0.000464	0.000743	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—CD36—metabolic syndrome X	0.000458	0.000733	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB4—IL6—metabolic syndrome X	0.000457	0.000731	CbGpPWpGaD
Lithium—Syncope—Metformin—metabolic syndrome X	0.000455	0.0257	CcSEcCtD
Lithium—GSK3B—Senescence and Autophagy in Cancer—IL6—metabolic syndrome X	0.000454	0.000726	CbGpPWpGaD
Lithium—GSK3A—Signaling by SCF-KIT—AKT1—metabolic syndrome X	0.000448	0.000716	CbGpPWpGaD
Lithium—GSK3B—B Cell Receptor Signaling Pathway—AKT1—metabolic syndrome X	0.000446	0.000714	CbGpPWpGaD
Lithium—Loss of consciousness—Metformin—metabolic syndrome X	0.000446	0.0252	CcSEcCtD
Lithium—GSK3A—Disease—NAMPT—metabolic syndrome X	0.000446	0.000713	CbGpPWpGaD
Lithium—GSK3A—Disease—GCK—metabolic syndrome X	0.000443	0.000708	CbGpPWpGaD
Lithium—IMPA2—Metabolism—ALB—metabolic syndrome X	0.000443	0.000708	CbGpPWpGaD
Lithium—GSK3B—PI-3K cascade—AKT1—metabolic syndrome X	0.000443	0.000708	CbGpPWpGaD
Lithium—GSK3A—Disease—APOC3—metabolic syndrome X	0.00044	0.000704	CbGpPWpGaD
Lithium—IMPA1—Metabolism—PPARG—metabolic syndrome X	0.000439	0.000702	CbGpPWpGaD
Lithium—GSK3A—Downstream signal transduction—IL6—metabolic syndrome X	0.000437	0.000698	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR—IL6—metabolic syndrome X	0.000434	0.000695	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB2—IL6—metabolic syndrome X	0.000432	0.000691	CbGpPWpGaD
Lithium—GSK3B—PI3K/AKT activation—AKT1—metabolic syndrome X	0.000432	0.000691	CbGpPWpGaD
Lithium—GSK3B—Immune System—PLA2G6—metabolic syndrome X	0.000432	0.000691	CbGpPWpGaD
Lithium—GSK3B—Disease—G6PD—metabolic syndrome X	0.000432	0.00069	CbGpPWpGaD
Lithium—IMPA1—Metabolism—INS—metabolic syndrome X	0.00043	0.000688	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—CRP—metabolic syndrome X	0.00043	0.000688	CbGpPWpGaD
Lithium—GSK3A—DAP12 signaling—IL6—metabolic syndrome X	0.00043	0.000688	CbGpPWpGaD
Lithium—GSK3B—GAB1 signalosome—AKT1—metabolic syndrome X	0.000429	0.000686	CbGpPWpGaD
Lithium—GSK3A—Downstream signaling of activated FGFR—AKT1—metabolic syndrome X	0.000428	0.000685	CbGpPWpGaD
Lithium—Discomfort—Metformin—metabolic syndrome X	0.000427	0.0241	CcSEcCtD
Lithium—GSK3A—Integrated Breast Cancer Pathway—AKT1—metabolic syndrome X	0.000424	0.000678	CbGpPWpGaD
Lithium—IMPA2—Metabolism—NOS3—metabolic syndrome X	0.000424	0.000677	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB4—AKT1—metabolic syndrome X	0.000422	0.000674	CbGpPWpGaD
Lithium—GSK3B—Disease—HDAC3—metabolic syndrome X	0.000421	0.000674	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—LPL—metabolic syndrome X	0.00042	0.000672	CbGpPWpGaD
Lithium—GSK3B—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—metabolic syndrome X	0.000419	0.00067	CbGpPWpGaD
Lithium—GSK3A—Immune System—CYBA—metabolic syndrome X	0.000417	0.000666	CbGpPWpGaD
Lithium—Oedema—Metformin—metabolic syndrome X	0.000414	0.0234	CcSEcCtD
Lithium—GSK3B—Adaptive Immune System—VCAM1—metabolic syndrome X	0.000412	0.000659	CbGpPWpGaD
Lithium—GSK3B—Disease—GCKR—metabolic syndrome X	0.000412	0.000659	CbGpPWpGaD
Lithium—Shock—Metformin—metabolic syndrome X	0.000407	0.023	CcSEcCtD
Lithium—GSK3B—DNA Damage Response (only ATM dependent)—AKT1—metabolic syndrome X	0.000407	0.00065	CbGpPWpGaD
Lithium—GSK3A—Disease—HMGA1—metabolic syndrome X	0.000405	0.000648	CbGpPWpGaD
Lithium—GSK3A—Insulin Signaling—AKT1—metabolic syndrome X	0.000405	0.000647	CbGpPWpGaD
Lithium—GSK3A—DAP12 interactions—IL6—metabolic syndrome X	0.000405	0.000647	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR in disease—IL6—metabolic syndrome X	0.000405	0.000647	CbGpPWpGaD
Lithium—GSK3A—Fc epsilon receptor (FCERI) signaling—IL6—metabolic syndrome X	0.000405	0.000647	CbGpPWpGaD
Lithium—GSK3A—Downstream signal transduction—AKT1—metabolic syndrome X	0.000403	0.000644	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR—IL6—metabolic syndrome X	0.000401	0.000641	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR—AKT1—metabolic syndrome X	0.000401	0.000641	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—CD36—metabolic syndrome X	0.000399	0.000639	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—HDAC3—metabolic syndrome X	0.000399	0.000639	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB2—AKT1—metabolic syndrome X	0.000399	0.000638	CbGpPWpGaD
Lithium—GSK3B—Immune System—TRIB3—metabolic syndrome X	0.000398	0.000636	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR in Cancer—IL6—metabolic syndrome X	0.000398	0.000636	CbGpPWpGaD
Lithium—GSK3A—DAP12 signaling—AKT1—metabolic syndrome X	0.000397	0.000635	CbGpPWpGaD
Lithium—GSK3A—Signaling by PDGF—IL6—metabolic syndrome X	0.000396	0.000633	CbGpPWpGaD
Lithium—Anorexia—Metformin—metabolic syndrome X	0.000395	0.0223	CcSEcCtD
Lithium—IMPA1—Metabolism—ALB—metabolic syndrome X	0.000395	0.000631	CbGpPWpGaD
Lithium—GSK3A—Downstream signaling events of B Cell Receptor (BCR)—AKT1—metabolic syndrome X	0.000391	0.000625	CbGpPWpGaD
Lithium—IMPA2—Metabolism—PTGS2—metabolic syndrome X	0.000387	0.000619	CbGpPWpGaD
Lithium—Hypotension—Metformin—metabolic syndrome X	0.000387	0.0218	CcSEcCtD
Lithium—GSK3A—Disease—GOT2—metabolic syndrome X	0.000386	0.000618	CbGpPWpGaD
Lithium—GSK3A—Disease—CYBA—metabolic syndrome X	0.000385	0.000615	CbGpPWpGaD
Lithium—IMPA1—Metabolism—NOS3—metabolic syndrome X	0.000377	0.000604	CbGpPWpGaD
Lithium—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000377	0.0213	CcSEcCtD
Lithium—GSK3A—Innate Immune System—IRS1—metabolic syndrome X	0.000376	0.000601	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—AGT—metabolic syndrome X	0.000376	0.000601	CbGpPWpGaD
Lithium—GSK3A—Fc epsilon receptor (FCERI) signaling—AKT1—metabolic syndrome X	0.000373	0.000597	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR in disease—AKT1—metabolic syndrome X	0.000373	0.000597	CbGpPWpGaD
Lithium—GSK3A—DAP12 interactions—AKT1—metabolic syndrome X	0.000373	0.000597	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—PPARA—metabolic syndrome X	0.000371	0.000594	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR—AKT1—metabolic syndrome X	0.00037	0.000592	CbGpPWpGaD
Lithium—Somnolence—Metformin—metabolic syndrome X	0.000368	0.0208	CcSEcCtD
Lithium—GSK3A—Metabolism of proteins—LEP—metabolic syndrome X	0.000368	0.000589	CbGpPWpGaD
Lithium—GSK3B—Disease—RBP4—metabolic syndrome X	0.000367	0.000587	CbGpPWpGaD
Lithium—GSK3B—Disease—TRIB3—metabolic syndrome X	0.000367	0.000587	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR in Cancer—AKT1—metabolic syndrome X	0.000367	0.000586	CbGpPWpGaD
Lithium—GSK3A—Signaling by PDGF—AKT1—metabolic syndrome X	0.000365	0.000584	CbGpPWpGaD
Lithium—Dyspepsia—Metformin—metabolic syndrome X	0.000365	0.0206	CcSEcCtD
Lithium—GSK3A—Adaptive Immune System—IRS1—metabolic syndrome X	0.000361	0.000577	CbGpPWpGaD
Lithium—Decreased appetite—Metformin—metabolic syndrome X	0.00036	0.0203	CcSEcCtD
Lithium—GSK3B—Signaling by SCF-KIT—IL6—metabolic syndrome X	0.000359	0.000574	CbGpPWpGaD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—IL6—metabolic syndrome X	0.000358	0.000573	CbGpPWpGaD
Lithium—Fatigue—Metformin—metabolic syndrome X	0.000357	0.0202	CcSEcCtD
Lithium—GSK3A—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000357	0.000571	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CD36—metabolic syndrome X	0.000353	0.000564	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—LEP—metabolic syndrome X	0.000352	0.000564	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	0.000351	0.000562	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—RBP4—metabolic syndrome X	0.000348	0.000556	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TRIB3—metabolic syndrome X	0.000348	0.000556	CbGpPWpGaD
Lithium—GSK3A—B Cell Activation—AKT1—metabolic syndrome X	0.000346	0.000552	CbGpPWpGaD
Lithium—IMPA1—Metabolism—PTGS2—metabolic syndrome X	0.000345	0.000552	CbGpPWpGaD
Lithium—GSK3A—Disease—SLC2A4—metabolic syndrome X	0.000344	0.000551	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling of activated FGFR—IL6—metabolic syndrome X	0.000343	0.000549	CbGpPWpGaD
Lithium—Feeling abnormal—Metformin—metabolic syndrome X	0.000341	0.0193	CcSEcCtD
Lithium—GSK3B—Adaptive Immune System—CD36—metabolic syndrome X	0.000339	0.000542	CbGpPWpGaD
Lithium—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000339	0.0191	CcSEcCtD
Lithium—GSK3A—Immune System—VCAM1—metabolic syndrome X	0.000338	0.000541	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—IL6—metabolic syndrome X	0.000338	0.00054	CbGpPWpGaD
Lithium—GSK3A—Disease—GOT1—metabolic syndrome X	0.000334	0.000533	CbGpPWpGaD
Lithium—GSK3B—Signaling by SCF-KIT—AKT1—metabolic syndrome X	0.000331	0.000529	CbGpPWpGaD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—AKT1—metabolic syndrome X	0.000331	0.000529	CbGpPWpGaD
Lithium—GSK3B—Disease—NAMPT—metabolic syndrome X	0.000329	0.000527	CbGpPWpGaD
Lithium—Abdominal pain—Metformin—metabolic syndrome X	0.000327	0.0185	CcSEcCtD
Lithium—GSK3B—Disease—GCK—metabolic syndrome X	0.000327	0.000523	CbGpPWpGaD
Lithium—GSK3B—BDNF signaling pathway—AKT1—metabolic syndrome X	0.000325	0.00052	CbGpPWpGaD
Lithium—GSK3B—Disease—APOC3—metabolic syndrome X	0.000325	0.00052	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—IL6—metabolic syndrome X	0.000323	0.000516	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—IL6—metabolic syndrome X	0.000321	0.000513	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—IL6—metabolic syndrome X	0.000319	0.000511	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CRP—metabolic syndrome X	0.000318	0.000509	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—IL6—metabolic syndrome X	0.000318	0.000508	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling of activated FGFR—AKT1—metabolic syndrome X	0.000317	0.000506	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—INS—metabolic syndrome X	0.000314	0.000503	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—AKT1—metabolic syndrome X	0.000312	0.000498	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—CCL2—metabolic syndrome X	0.000309	0.000495	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—APOC3—metabolic syndrome X	0.000308	0.000493	CbGpPWpGaD
Lithium—GSK3B—Immune System—CYBA—metabolic syndrome X	0.000308	0.000492	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—PPARG—metabolic syndrome X	0.000307	0.000491	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—IGF1—metabolic syndrome X	0.000304	0.000486	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—INS—metabolic syndrome X	0.000301	0.000481	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL18—metabolic syndrome X	0.000299	0.000479	CbGpPWpGaD
Lithium—GSK3B—Disease—HMGA1—metabolic syndrome X	0.000299	0.000479	CbGpPWpGaD
Lithium—GSK3B—Insulin Signaling—AKT1—metabolic syndrome X	0.000299	0.000478	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—IL6—metabolic syndrome X	0.000299	0.000478	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—IL6—metabolic syndrome X	0.000299	0.000478	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—IL6—metabolic syndrome X	0.000299	0.000478	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—AKT1—metabolic syndrome X	0.000298	0.000476	CbGpPWpGaD
Lithium—Asthenia—Metformin—metabolic syndrome X	0.000297	0.0168	CcSEcCtD
Lithium—GSK3B—Signaling by EGFR—IL6—metabolic syndrome X	0.000296	0.000474	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—AKT1—metabolic syndrome X	0.000296	0.000474	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HDAC3—metabolic syndrome X	0.000295	0.000472	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—AKT1—metabolic syndrome X	0.000295	0.000471	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—IL6—metabolic syndrome X	0.000294	0.00047	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—AKT1—metabolic syndrome X	0.000293	0.000469	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—IL6—metabolic syndrome X	0.000292	0.000468	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling events of B Cell Receptor (BCR)—AKT1—metabolic syndrome X	0.000289	0.000462	CbGpPWpGaD
Lithium—GSK3B—Disease—GOT2—metabolic syndrome X	0.000286	0.000457	CbGpPWpGaD
Lithium—GSK3B—Disease—CYBA—metabolic syndrome X	0.000284	0.000454	CbGpPWpGaD
Lithium—Diarrhoea—Metformin—metabolic syndrome X	0.000283	0.016	CcSEcCtD
Lithium—GSK3A—Disease—APOB—metabolic syndrome X	0.000283	0.000453	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—HTR2C—metabolic syndrome X	0.000278	0.000445	CbGpPWpGaD
Lithium—GSK3A—Immune System—CD36—metabolic syndrome X	0.000278	0.000445	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—IRS1—metabolic syndrome X	0.000278	0.000444	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—AKT1—metabolic syndrome X	0.000276	0.000441	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—AKT1—metabolic syndrome X	0.000276	0.000441	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—AKT1—metabolic syndrome X	0.000276	0.000441	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—IL6—metabolic syndrome X	0.000276	0.000441	CbGpPWpGaD
Lithium—Dizziness—Metformin—metabolic syndrome X	0.000274	0.0155	CcSEcCtD
Lithium—GSK3B—Signaling by EGFR—AKT1—metabolic syndrome X	0.000273	0.000437	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—AKT1—metabolic syndrome X	0.000271	0.000433	CbGpPWpGaD
Lithium—GSK3A—Disease—LPL—metabolic syndrome X	0.00027	0.000432	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—IL6—metabolic syndrome X	0.00027	0.000432	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—AKT1—metabolic syndrome X	0.00027	0.000431	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CYBA—metabolic syndrome X	0.000269	0.000431	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—IRS1—metabolic syndrome X	0.000267	0.000426	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—IL6—metabolic syndrome X	0.000265	0.000424	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000264	0.000422	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—GHRL—metabolic syndrome X	0.000264	0.000422	CbGpPWpGaD
Lithium—Vomiting—Metformin—metabolic syndrome X	0.000263	0.0149	CcSEcCtD
Lithium—Rash—Metformin—metabolic syndrome X	0.000261	0.0147	CcSEcCtD
Lithium—Dermatitis—Metformin—metabolic syndrome X	0.000261	0.0147	CcSEcCtD
Lithium—GSK3B—Focal Adhesion—AKT1—metabolic syndrome X	0.000261	0.000417	CbGpPWpGaD
Lithium—Headache—Metformin—metabolic syndrome X	0.000259	0.0146	CcSEcCtD
Lithium—GSK3B—Signaling Pathways—TRIB3—metabolic syndrome X	0.000257	0.000411	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—RBP4—metabolic syndrome X	0.000257	0.000411	CbGpPWpGaD
Lithium—GSK3B—B Cell Activation—AKT1—metabolic syndrome X	0.000255	0.000408	CbGpPWpGaD
Lithium—GSK3B—Disease—SLC2A4—metabolic syndrome X	0.000254	0.000407	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—AKT1—metabolic syndrome X	0.000254	0.000407	CbGpPWpGaD
Lithium—GSK3A—Immune System—CRP—metabolic syndrome X	0.000251	0.000401	CbGpPWpGaD
Lithium—GSK3B—Immune System—VCAM1—metabolic syndrome X	0.00025	0.0004	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CNR1—metabolic syndrome X	0.00025	0.000399	CbGpPWpGaD
Lithium—GSK3B—Disease—GOT1—metabolic syndrome X	0.000246	0.000394	CbGpPWpGaD
Lithium—Nausea—Metformin—metabolic syndrome X	0.000246	0.0139	CcSEcCtD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—AKT1—metabolic syndrome X	0.000244	0.000391	CbGpPWpGaD
Lithium—GSK3B—TCF dependent signaling in response to WNT—AKT1—metabolic syndrome X	0.000234	0.000373	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—APOC3—metabolic syndrome X	0.000228	0.000364	CbGpPWpGaD
Lithium—GSK3A—Disease—APOE—metabolic syndrome X	0.000227	0.000362	CbGpPWpGaD
Lithium—GSK3B—RNF mutants show enhanced WNT signaling and proliferation—AKT1—metabolic syndrome X	0.000226	0.000362	CbGpPWpGaD
Lithium—GSK3A—Disease—APOA1—metabolic syndrome X	0.000224	0.000358	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL18—metabolic syndrome X	0.000221	0.000354	CbGpPWpGaD
Lithium—GSK3A—Immune System—IRS1—metabolic syndrome X	0.000219	0.00035	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—IL6—metabolic syndrome X	0.000217	0.000347	CbGpPWpGaD
Lithium—GSK3B—Signaling by WNT in cancer—AKT1—metabolic syndrome X	0.00021	0.000336	CbGpPWpGaD
Lithium—GSK3B—Disease—APOB—metabolic syndrome X	0.000209	0.000334	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HTR2C—metabolic syndrome X	0.000206	0.000329	CbGpPWpGaD
Lithium—GSK3B—Immune System—CD36—metabolic syndrome X	0.000205	0.000329	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IGF2—metabolic syndrome X	0.000204	0.000326	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—IL6—metabolic syndrome X	0.000204	0.000326	CbGpPWpGaD
Lithium—GSK3A—Disease—IRS1—metabolic syndrome X	0.000202	0.000323	CbGpPWpGaD
Lithium—GSK3B—Disease—LPL—metabolic syndrome X	0.0002	0.000319	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CYBA—metabolic syndrome X	0.000199	0.000318	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—APOB—metabolic syndrome X	0.000198	0.000317	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—GHRL—metabolic syndrome X	0.000195	0.000312	CbGpPWpGaD
Lithium—IMPA2—Metabolism—AKT1—metabolic syndrome X	0.000195	0.000311	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CCL5—metabolic syndrome X	0.000194	0.000309	CbGpPWpGaD
Lithium—GSK3A—Disease—INS—metabolic syndrome X	0.000194	0.000309	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000193	0.000308	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—LPL—metabolic syndrome X	0.000189	0.000303	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—AKT1—metabolic syndrome X	0.000188	0.0003	CbGpPWpGaD
Lithium—GSK3B—Immune System—CRP—metabolic syndrome X	0.000185	0.000296	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CNR1—metabolic syndrome X	0.000185	0.000295	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—IL6—metabolic syndrome X	0.000184	0.000295	CbGpPWpGaD
Lithium—GSK3A—Disease—SERPINE1—metabolic syndrome X	0.000178	0.000284	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—TGFB1—metabolic syndrome X	0.000175	0.000279	CbGpPWpGaD
Lithium—IMPA1—Metabolism—AKT1—metabolic syndrome X	0.000174	0.000277	CbGpPWpGaD
Lithium—GSK3B—Signaling by Wnt—AKT1—metabolic syndrome X	0.000173	0.000277	CbGpPWpGaD
Lithium—GSK3A—Disease—NOS3—metabolic syndrome X	0.00017	0.000271	CbGpPWpGaD
Lithium—GSK3B—Disease—APOE—metabolic syndrome X	0.000167	0.000268	CbGpPWpGaD
Lithium—GSK3B—Disease—APOA1—metabolic syndrome X	0.000165	0.000265	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—TNF—metabolic syndrome X	0.000163	0.000261	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—AGT—metabolic syndrome X	0.000162	0.000259	CbGpPWpGaD
Lithium—GSK3B—Immune System—IRS1—metabolic syndrome X	0.000162	0.000259	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—LEP—metabolic syndrome X	0.000159	0.000254	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—APOE—metabolic syndrome X	0.000159	0.000254	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—IL6—metabolic syndrome X	0.000157	0.000251	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—APOA1—metabolic syndrome X	0.000157	0.000251	CbGpPWpGaD
Lithium—GSK3A—Disease—PTGS2—metabolic syndrome X	0.000155	0.000248	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IGF2—metabolic syndrome X	0.000151	0.000241	CbGpPWpGaD
Lithium—GSK3B—Disease—IRS1—metabolic syndrome X	0.000149	0.000239	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—APOB—metabolic syndrome X	0.000146	0.000234	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—AKT1—metabolic syndrome X	0.000145	0.000232	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCL5—metabolic syndrome X	0.000143	0.000229	CbGpPWpGaD
Lithium—GSK3B—Disease—INS—metabolic syndrome X	0.000143	0.000229	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000142	0.000228	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IRS1—metabolic syndrome X	0.000141	0.000226	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—LPL—metabolic syndrome X	0.00014	0.000224	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—AKT1—metabolic syndrome X	0.000139	0.000223	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—INS—metabolic syndrome X	0.000136	0.000217	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CCL2—metabolic syndrome X	0.000133	0.000213	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—IL6—metabolic syndrome X	0.000132	0.00021	CbGpPWpGaD
Lithium—GSK3B—Disease—SERPINE1—metabolic syndrome X	0.000131	0.00021	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IGF1—metabolic syndrome X	0.000131	0.00021	CbGpPWpGaD
Lithium—GSK3B—Disease—NOS3—metabolic syndrome X	0.000125	0.000201	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000124	0.000199	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—AKT1—metabolic syndrome X	0.000121	0.000194	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—AGT—metabolic syndrome X	0.00012	0.000191	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NOS3—metabolic syndrome X	0.000119	0.00019	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—APOE—metabolic syndrome X	0.000117	0.000187	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—LEP—metabolic syndrome X	0.000117	0.000187	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—IL6—metabolic syndrome X	0.000116	0.000186	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—APOA1—metabolic syndrome X	0.000116	0.000185	CbGpPWpGaD
Lithium—GSK3B—Disease—PTGS2—metabolic syndrome X	0.000115	0.000183	CbGpPWpGaD
Lithium—GSK3A—Disease—TGFB1—metabolic syndrome X	0.000112	0.000179	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—AKT1—metabolic syndrome X	0.000107	0.000171	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IRS1—metabolic syndrome X	0.000105	0.000167	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—AKT1—metabolic syndrome X	0.000103	0.000165	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—INS—metabolic syndrome X	0.0001	0.00016	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCL2—metabolic syndrome X	9.85e-05	0.000158	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IGF1—metabolic syndrome X	9.69e-05	0.000155	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SERPINE1—metabolic syndrome X	9.2e-05	0.000147	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL6—metabolic syndrome X	9.16e-05	0.000146	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NOS3—metabolic syndrome X	8.78e-05	0.00014	CbGpPWpGaD
Lithium—GSK3A—Disease—IL6—metabolic syndrome X	8.46e-05	0.000135	CbGpPWpGaD
Lithium—GSK3A—Immune System—AKT1—metabolic syndrome X	8.45e-05	0.000135	CbGpPWpGaD
Lithium—GSK3B—Disease—TGFB1—metabolic syndrome X	8.29e-05	0.000133	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TGFB1—metabolic syndrome X	7.86e-05	0.000126	CbGpPWpGaD
Lithium—GSK3A—Disease—AKT1—metabolic syndrome X	7.8e-05	0.000125	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL6—metabolic syndrome X	6.77e-05	0.000108	CbGpPWpGaD
Lithium—GSK3B—Disease—IL6—metabolic syndrome X	6.25e-05	9.99e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—AKT1—metabolic syndrome X	6.24e-05	9.98e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IL6—metabolic syndrome X	5.92e-05	9.47e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TGFB1—metabolic syndrome X	5.81e-05	9.28e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—AKT1—metabolic syndrome X	5.76e-05	9.22e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—AKT1—metabolic syndrome X	5.46e-05	8.73e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IL6—metabolic syndrome X	4.38e-05	7e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—AKT1—metabolic syndrome X	4.04e-05	6.45e-05	CbGpPWpGaD
